Dr. Gilles Salles will join MorphoSys and Incyte leadership as an expert speaker.
- Dr. Gilles Salles will join MorphoSys and Incyte leadership as an expert speaker.
- The conference call and webcast will be held on Tuesday, September 29, 2020 from 9:00 - 11:00 a.m. EDT / 3:00 - 5:00 p.m. CEST.
- In January 2020, MorphoSys and Incyte entered into a collaboration and licensing agreement to further develop and commercialize tafasitamab globally.
- Serious infections, including infections that can cause death, have happened in people during treatments with MONJUVI and after the last dose.